CDHA CAAR

A. “NIH Health Care Systems Research Collaboratory – Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional),” (RFA-AT-22-001, National Institute on Aging, in conjunction with other agencies, application deadlines December 15, 2021, June 17, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AT-22-001.html

B. “NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed),” (RFA-NS-21-025, National Institute on Aging, in conjunction with other agencies, application deadline November 1, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-025.html

“Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed),” (PAR-22-048, National Institute on Aging, in conjunction with other agencies, application deadline March 11, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-048.html

“HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required),” (RFA-NS-22-002, National Institute on Aging, in conjunction with other agencies, application deadline December 9, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-002.html

“Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required),” (PAR-21-349, a reissue of PAR-21-144, National Institute on Aging, in conjunction with other agencies, application deadlines June 21, 2022, June 21, 2023, and June 21, 2024). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed),” (PAR-21-350); and, “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required),” (PAR-21-352).

grants.nih.gov/grants/guide/pa-files/PAR-21-349.html

“Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed),” (PAR-22-037, National Institute of Health, in conjunction with other agencies, application deadline February 4, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-22-037.html

A. “NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed),” (PAR-22-021, National Institute on Aging, in conjunction with other agencies, application deadlines May 25, 2022, May 25, 2023, and May 25, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-22-021.html

B. “NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed),” (PAR-21-351, National Institute on Aging, application deadline Feb. 12, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-21-351.html

A. “Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional),” (PAR-21-311 , a reissue of PAR-18-835, National Institute on Aging, in conjunction with other agencies, application deadlines Dec. 9, 2021, Nov. 15, 2022, and Nov. 15, 2023). Note: This is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional),” (PAR-21-319).

grants.nih.gov/grants/guide/pa-files/PAR-21-311.html

B. “Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18),” (PA-21-267, Agency for Healthcare Research and Quality, application deadlines Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PA-21-267.html

A. “Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed),” (PAR-22-029, National Institute on Aging, in conjunction with other agencies, application Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-22-029.html

B. “NINDS Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed),” (PAR-22-022, National Institute on Aging, in conjunction with other agencies, application deadlines March 12, July 12, and November 12).

grants.nih.gov/grants/guide/pa-files/PAR-22-022.html

A. “Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed),” (PAR-21-271, a reissue of PAR-19-343, National Institute on Aging, in conjunction with other agencies, first application date Oct. 27, 2021). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): ” Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required),” (PAR-21-272); “Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required (BESH)),” (PAR-21-273).

grants.nih.gov/grants/guide/pa-files/PAR-21-271.html

B. “Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed),” (PAR-21-314, National Institute on Aging, in conjunction with other agencies, application deadline October 20, 2021). Note: This is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Blueprint MedTech Translator (UG3/UH3 – Clinical Trial Optional),” (PAR-21-315).

grants.nih.gov/grants/guide/pa-files/PAR-21-314.html

C. “Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed),” (PAR-22-026, National Institute on Aging, in conjunction with other agencies, application deadline November 8, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-22-026.html

“Dementia Care and Caregiver Support Intervention Research (R01 Clinical),” (PAR-21-307, a reissue of RFA-AG-18-030, National Institute on Aging, applications deadlines Oct. 7, 2021, Feb. 10, 2022, Oct. 11, 2022, Feb. 10, 2023, Oct. 10, 2023, and Feb. 13, 2024). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required),” (PAR-21-308).

grants.nih.gov/grants/guide/pa-files/PAR-21-308.html

“Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed),” (PAR-22-024, a reissue of RFA-NS-19-026, National Institute on Aging, in conjunction with other agencies, application deadline November 10, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-22-024.html

A. “Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed),” (PAR-22-023, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 22, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-22-023.html

B. “Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed),” (RFA-NS-22-001, a reissue of of RFA-NS-16-022, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 22, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-001.html

C. “Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed),” (RFA-NS-22-006, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 26, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-006.html

“BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed),” (RFA-MH-21-235, National Institute of Aging, in conjunction with other agencies, application deadline November 9, 2021). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed),” (RFA-MH-21-236); and, “BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed),” (RFA-MH-21-237).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-235.html

“Lifespan Respite Care Program: State Program Enhancement Grants – Reposting Opportunity to Apply,” (HHS-2021-ACL-AOA-LRLI-0115, application deadline Aug. 23, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=334854

“Limited Competition: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed),” (RFA-AG-22-023, National Institute on Aging, application deadline October 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-023.html

A. “Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed),” (RFA-AG-22-015, National Institute on Aging, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-015.html

B. “Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed),” (RFA-AG-22-021, National Institute on Aging, application deadline November 2, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-021.html

C. “Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimer’s Disease and Related Dementias (R61/R33 Clinical Trial Required),” (RFA-AG-22-024, National Institute on Aging, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-024.html

D. “Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required),” (RFA-HL-22-014, a reissue of RFA-HL-21-003, National Institute on Aging, in conjunction with other agencies, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-014.html

E. “BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional),” (RFA-MH-21-205, a reissue of RFA-MH-19-400, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 13, 2021, Oct. 11, 2022, and Oct. 11, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-205.html

“Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed),” (PAR-21-281, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, 2022 and Feb. 5, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans),” (PAR-21-280).

grants.nih.gov/grants/guide/pa-files/PAR-21-281.html

A. “PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-21-259, a reissue of PA-20-260, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 5, Jan. 5, and April 5). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-21-260); “PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-21-261); and “PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-21-262).

grants.nih.gov/grants/guide/pa-files/PA-21-259.html

B. “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans),” (PAR-21-280, National Institute on Aging, deadline for application March 5, 2022, March 5, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed),” (PAR-21-281).

grants.nih.gov/grants/guide/pa-files/PAR-21-280.html

C. “Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed),” (RFA-AG-22-022, National Institute on Aging, Letter of Intent due date September 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-022.html

D. “Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional),” (RFA-AG-22-027, National Institute on Aging, Letter of Intent Due Data October 2, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-027.html

A. “Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed),” (RFA-AG-22-025, National Institute on Aging, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-025.html

B. “The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional),” (PAR-21-275, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-21-275.html

A. “Role of Adaptive Immunity in Etiology of Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Optional),” (RFA-AG-22-017, National Institute on Aging, application deadline Oct. 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-017.html

B. “Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed),” (RFA-AG-22-018, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-018.html

A. “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed),” (RFA-AG-22-003, National Institute on Aging, application deadline October 4, 2021). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed),” (RFA-AG-22-004); “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional),” (RFA-AG-22-007); and, “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional),” (RFA-AG-22-014).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-003.html

B. “High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed),” (RFA-AG-22-019, National Institute on Aging, application deadline October 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-019.html

C. “BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed),” (RFA-NS-21-026, a reissue of RFA-NS-18-020, National Institute on Aging, in conjunction with other agencies, application deadlines Oct. 29, 2021, May 2, 2022, Oct. 28, 2022, May 1, 2023, and Oct. 27, 2023). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed),” (RFA-NS-21-027).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-026.html

D. “HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed),” (RFA-NS-21-029, reissue of RFA-NS-21-016, National Institute on Aging, in conjunction with other agencies, application deadline July 19, 2021, Oct. 13, 2021, June 9, 2022, Oct. 11, 2022, June 9, 2023, and Oct. 10, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-029.html

A. “National Technical Assistance Center on Kinship and Grandfamilies,” (HHS-2021-ACL-AOA-TAKG-0103, deadline for applications July 26, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=333517

B. “Alzheimer’s Disease Programs Initiative – Grants to States and Communities (Round Two),” (HHS-2021-ACL-AOA-ADPI-0086, deadline for applications August 2, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=331701

“NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed),” (PAR-21-217, National Institute on Aging, first application deadline August 8, 2021). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31),” (PAR-21-218); and, “NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed),” (PAR-21-220).

grants.nih.gov/grants/guide/pa-files/PAR-21-217.html

“Alzheimer’s Disease Programs Initiative – Dementia Capability in Indian Country,” (HHS-2021-ACL-AOA-ADPI-0104, application deadline July 19, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=333594

“Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required),” (PAR-21-154, a reissue of PAR-19-133, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 25, June 25, and Oct. 25). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed),” (PAR-21-155).

grants.nih.gov/grants/guide/pa-files/PAR-21-154.html

“BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed),” (RFA-MH-21-175, a reissue of RFA-MH-19-136, National Institute on Aging, in conjunction with other agencies, application deadline October 08, 2021, October 07, 2022, and October 08, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-175.html

“Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional),” (PAR-21-233, a reissue of PAR-21-162, National Institute on Aging, in conjunction with other agencies, application deadlines August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-21-233.html

“National Adult Protective Services Training Center,” (HHS-2021-ACL-AOA-EJRC-0101, application deadline May 29, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=332662

A. “Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed),” (PAR-21-213, National Institute on Aging, in conjunction with other agencies, letter of intent due dates May 9, 2021; October 8, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-21-213.html

B. “Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimer’s Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional),” (PAR-21-207, National Institute on Aging, letter of intent deadline September 15, 2021, January 26, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-21-207.html

“Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional),” (PAR-21-162, National Institute on Aging, in conjunction with other agencies, application deadlines August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional),” (PAR-21-163).

grants.nih.gov/grants/guide/pa-files/PAR-21-162.html

A. “Innovations in Nutrition Programs and Services – Statewide Research,” (HHS-2021-ACL-AOA-INNU-0092, application deadline May 24, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=332358

B. “Innovations in Nutrition Programs and Services – Community Research,” (HHS-2021-ACL-AOA-INNU-0084, application deadline May 24, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=332357

A. “Limited Competition: Alzheimer’s Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed),” (PAR-21-212, National Institute on Aging, application deadline Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-21-212.html

B. “Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer’s Disease and Related Dementias (R25 – Clinical Trial Not Allowed),” (RFA-AG-22-010, National Institute on Aging, application deadline October 4, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-010.html

C. “Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional),” (RFA-MD-21-004, National Institute on Aging, in conjunction with other agencies, application deadline August 24, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-MD-21-004.html

D. “Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional),” (RFA-TW-21-001, a reissue of RFA-TW-14-001, National Institute on Aging, in conjunction with other agencies, application deadline July 8, 2021). Note: here is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) – Research Training (Collaborative U2R Clinical Trial Optional),” (RFA-TW-21-002).

grants.nih.gov/grants/guide/rfa-files/RFA-TW-21-001.html

A. “Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed),” (PAR-21-169, National Institute on Aging, in conjunction with other agencies, application deadlines May 26, 2021, May 26, 2022, and May 26, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 – Clinical Trial Not Allowed),” (PAR-21-173).

grants.nih.gov/grants/guide/pa-files/PAR-21-169.html

B. “High-Priority Behavioral and Social Research Networks in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R24 Clinical Trial Optional),” (RFA-AG-22-012, reissue of RFA-AG-19-016, National Institute on Aging, application deadline June 23, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-012.html

C. “High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional),” (RFA-AG-22-013, a reissue of RFA-AG-19-015, National Institute on Aging, application deadline June 23, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-013.html

“Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) Activity Code,” (PAR-21-163, National Institute on Aging). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Small Business Innovation Research (SBIR) Cooperative Agreements – Fast-Track,” (PAR-20-111); and, “Phase 1 Exploratory/Developmental Cooperative Agreement/Exploratory/Developmental Cooperative Agreement Phase II,” (PAR-20-122).

grants.nih.gov/grants/guide/pa-files/PAR-21-163.html

“AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed),” (PAR-21-141, National Institute on Aging, application deadlines May 25, 2021; May 25, 2022; May 25, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-21-141.html

“The Midlife in the United States Study (U19 Clinical Trial Not Allowed),” (PAR-21-156, National Institute on Aging, application deadlines April 26, 2021 and November 18, 2021). Note:  There is a companion funding announcement (follow the link under “Companion Funding Opportunity” ): “The Midlife in the United States Study – Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed),” (PAR-21-157).

grants.nih.gov/grants/guide/pa-files/PAR-21-156.html

“Alzheimer’s Disease Programs Initiative – Grants to States and Communities,” (HHS-2021-ACL-AOA-ADPI-0083, application deadline April 26, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=330640

“NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed),” (PA-21-151, a reissue of PA-20-207, National Institute on Aging, in conjunction with other agencies). Note: List of application deadlines available at the site.

grants.nih.gov/grants/guide/pa-files/PA-21-151.html

A. “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required),” (PAR-21-144, a reissues of of PAR-19-384, US National Institute on Aging).

grants.nih.gov/grants/guide/pa-files/PAR-21-144.html

B. “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed),” (PAR-21-145, a reissue of PAR-19-373, National Institute on Aging, ).

grants.nih.gov/grants/guide/pa-files/PAR-21-145.html

“NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 – Independent Clinical Trial Not Allowed),” (PAR-20-317, a reissue of PAR-17-290, National Institute on Aging, application deadlines May 25, 2021; May 25, 2022; May 25, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-20-317.html

“NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed),” (PAR-21-106, reissue of PAR-17-287, National Institute on Aging, application deadlines Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PAR-21-106.html

A. “Infectious Etiology of Alzheimer’s Disease (R01 Clinical Trial Optional),” (RFA-AG-21-034, National Institute on Aging, application deadline March 31, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-034.html

B. “BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed),” (RFA-EY-21-001, a reissue of RFA-EY-18-001, National Institute on Aging, in conjunction with other agencies, application deadlines May 3, 2021; October 29, 2021; May 2, 2022; October 28, 2022; May 1, 2023; October 27, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-001.html

“Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional),” (PAR-21-100, National Institute on Aging, in conjunction with other agencies, application deadlines February 5, 2021, February 5, 2022, February 5, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional),” (PAR-21-099).

grants.nih.gov/grants/guide/pa-files/PAR-21-100.html

A. “2021 Empowering Communities to Reduce Falls and Falls Risk,” (HHS-2021-ACL-AOA-FPSG-0015, application deadline February 2, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=329763

B. “2021 Integrated Networks to Deliver and Sustain Evidence-Based Falls Prevention Programs,” (HHS-2021-ACL-AOA-FPSG-0017, application deadline February 2, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=329762

C. “2021 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs,” (HHS-2021-ACL-AOA-CSSG-0014, application deadline February 2, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=329804

“Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed),” (RFA-AG-22-002, National Institute on Aging, application deadline June 15, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-002.html

“Interventional Cooperative Agreement Program Social Security Administration,” (ICAP-ICA-21-001, application deadline April 16, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=329609

“2021 Empowering Communities to Address Behavioral Health and Chronic Pain through Chronic Disease Self-Management Education Programs,” (HHS-2021-ACL-AOA-CSSG-0018, application deadline Feb. 2, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=329787

A. “Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required),” (PAR-20-309, a reissue of PAR-18-513, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-20-309.html

B. “Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional),” (PAR-21-068, a reissue of PAR-18-189, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional),” (PAR-21-069).

grants.nih.gov/grants/guide/pa-files/PAR-21-068.html

C. “Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed),” (RFA-NS-21-005, a reissue of RFA-NS-16-020, National Institute on Aging, in conjunction with other agencies, application deadline March 9, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-NS-21-004).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-005.html

A. “Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed),” (PAR-21-080, a reissue of PA-17-041, National Institute on Aging, in conjunction with other agencies, application deadlines Mar. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional),” (PAR-21-081).

grants.nih.gov/grants/guide/pa-files/PAR-21-080.html

B. “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed),” (PA-21-071, National Institute on Aging, in conjunction with other agencies, due dates by awarding IC).

grants.nih.gov/grants/guide/pa-files/PA-21-071.html

“Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed),” (PA-21-071, a reissue of PA-20-222, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-21-071.html